Clinical trials
Enrolling by invitation Non-alcoholic Fatty Liver Disease trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mahidol University | 2 |
| Federico II University | 1 |
| Helsinki University Central Hospital | 1 |
| Military University Hospital, Prague | 1 |
| National Taiwan University Hospital | 1 |
| Northwestern University | 1 |
| University of Agriculture, Peshawar | 1 |
| University of Missouri-Columbia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 9 |
| Fatty Liver | 4 |
| Metabolic Syndrome | 4 |
| Cardiovascular Diseases | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Insulin Resistance | 2 |
| Liver Diseases | 2 |
| Digestive System Diseases | 1 |
| Hepatitis B, Chronic | 1 |
| Inflammation | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.